Ivabradine and propranolol were evaluated against placebo in a randomized crossover trial for the treatment of postural orthostatic tachycardia syndrome.
Absolute Event Rate: 0% vs 0%
Postural orthostatic tachycardia syndrome (POTS) is characterized by an excessive orthostatic heart rate increase and lacks approved pharmacologic therapies.
“Symptom and quality-of-life improvements were selective rather than uniform, and patient preferences were divided between active medications, highlighting interindividual variability in tolerability and perceived benefit. Treatment selection should be individualized based on clinical phenotype an...”
Uppal et al. (Fri,) reported a other. Ivabradine and propranolol were evaluated against placebo in a randomized crossover trial for the treatment of postural orthostatic tachycardia syndrome.